40TUDE CURING COLON CANCER
40tude is an innovative and successful charity that is tackling colon cancer.Since the organisation was founded in 2011 we have raised over £2.5 million to raise awareness and support ground-breaking research into the early diagnosis and treatment of colon (bowel) cancer. We are helping to fund ground-breaking research programmes at St. Mark's Hospital, the national bowel hospital.
Financial health, per its FY2024 accounts
The accounts state that unrestricted reserves stood at £461,953, which the trustees describe as sufficient to cover working capital and future research commitments. The charity reported a net expenditure of £8,686 for the year, resulting in a slight decrease in total funds from the previous year. The trustees consider the current state of finances to be sound.
What the accounts disclose
“We had unrestricted reserves of £461,953. These funds are held in order to cover working capital and short-term expenses to operate the charity and also to cover current and future commitments to fund research projects and to advance further the objectives of the charity.” — page 7
Funders the charity credits
- LV=
- OSTC
- Hermes Investment Management
Structured financials (annual return, FY ending 31/12/2022)
Trustees
- GORDON MOOREchair
- Claire Elizabeth Godwin
- Jonathan Aucamp
- Mark Lee-Amies
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £292k | £301k |
| 31/12/2023 | £333k | £550k |
| 31/12/2022 | £760k | £359k |
| 31/12/2021 | £115k | £151k |
| 31/12/2020 | £271k | £286k |
Common questions
Is 40TUDE CURING COLON CANCER financially healthy?
Per its FY2024 accounts: The accounts state that unrestricted reserves stood at £461,953, which the trustees describe as sufficient to cover working capital and future research commitments. The charity reported a net expenditure of £8,686 for the year, resulting in a slight decrease in total funds from the previous year. The trustees consider the current state of finances to be sound. Its FY2024 accounts were independently examined.
Who funds 40TUDE CURING COLON CANCER?
Funders whose own accounts filings name 40TUDE CURING COLON CANCER as a grant recipient include The Caledonia Investments Charitable Foundation, THE BLAKEY FOUNDATION.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| The Caledonia Investments Charitable Foundation | FY2022 | £1k | |
| THE BLAKEY FOUNDATION | FY2025 | £1k | |
| The Caledonia Investments Charitable Foundation | FY2023 | £970 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SIR SAMUEL SCOTT OF YEWS TRUST | 3 | £29k |
| THE SIMON GIBSON CHARITABLE TRUST | 3 | £26k |
| THE SIR JAMES ROLL CHARITABLE TRUST | 3 | £16k |
| ROBERT LUFF FOUNDATION LIMITED | 2 | £342k |
| CHRISTOS LAZARI FOUNDATION | 2 | £94k |
| THE WILLIAM ALLEN YOUNG CHARITABLE TRUST | 2 | £37k |
| THE BILLMEIR CHARITABLE TRUST | 2 | £25k |
| CECIL PILKINGTON CHARITABLE TRUST | 2 | £23k |
Charities like this
- GUTS
- Bowel Research UK
- TENOVUS CANCER CARE
- BOWEL CANCER UK
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- PLANETS CANCER CHARITY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| 40TUDE CURING COLON CANCER | £292k | — | 0 | within | — | no doubt |
| GUTS | £317k | — | 0 | unclear | — | no doubt |
| Bowel Research UK | £1.6m | more than £60,000 | 1 | above | 21.5% | no doubt |
| TENOVUS CANCER CARE | £8.6m | £110,001 - £120,000 | — | unclear | — | no doubt |
| BOWEL CANCER UK | £6.6m | — | — | below | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |